financetom
Business
financetom
/
Business
/
Cidara Therapeutics Prices $350 Million Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cidara Therapeutics Prices $350 Million Public Offering
Jun 25, 2025 1:35 AM

04:14 AM EDT, 06/25/2025 (MT Newswires) -- Cidara Therapeutics ( CDTX ) said Tuesday it has priced an underwritten public offering of 8 million shares at $44 per share for gross proceeds of $350 million.

Underwriters have been granted a 30-day option to purchase up to about 1.2 million additional shares.

The offering is set to close Thursday, subject to the satisfaction of customary closing conditions.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gemini Stock Jumps 45% in Early Trades After IPO
Gemini Stock Jumps 45% in Early Trades After IPO
Sep 12, 2025
Shares of Gemini (GEMI) opened at $41 a share on the Nasdaq Global Select Market on Friday, rising 45% from last night's IPO price. The crypto exchange, which is run by Tyler and Cameron Winklevoss, priced its IPO at $28 a share, valuing the company at around $3.3 billion. It had sold 15.2 million shares, raising $425 million. Gemini posted...
Thales, Airbus, Leonardo eye initial agreement on 10 billion-euro satellite JV, sources say
Thales, Airbus, Leonardo eye initial agreement on 10 billion-euro satellite JV, sources say
Sep 12, 2025
LONDON/PARIS (Reuters) -Europe's aerospace groups Leonardo, Thales and Airbus have redoubled efforts to combine their satellite businesses into a 10 billion-euro ($11.7 billion) joint venture and are working towards hammering out an initial agreement in coming weeks, sources close to the matter told Reuters in recent days.  Under Project Bromo, named after an Indonesian volcano, the three companies plan to...
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
Sep 12, 2025
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. ( CURX ) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced that Dominari Securities LLC, which acted as the lead underwriter for the Company’s underwritten initial public offering (the “Offering” or the “IPO”), has exercised...
Six Flags Q3 Tracking In Line, Attendance Ahead of Expectations, Truist Says
Six Flags Q3 Tracking In Line, Attendance Ahead of Expectations, Truist Says
Sep 12, 2025
03:29 PM EDT, 09/12/2025 (MT Newswires) -- Six Flags Entertainment ( FUN ) Q3 performance is tracking in line with expectations, offering some reassurance after a weather-impacted Q2 and a major full-year guidance cut, Truist Securities said in a note Friday. The comments followed the company's update that revenue for the nine weeks through Aug. 31 fell 2% year over...
Copyright 2023-2026 - www.financetom.com All Rights Reserved